Definitive Healthcare Corp. (DH)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 118 | 166 | 223 | 251 | 252 | 242 | 233 | 221 |
| Operating profit | $m | -21 | - | ||||||
| Net profit | $m | -53 | -52 | -7 | -202 | -413 | -139 | -168 | - |
| EPS reported | $ | -1.30 | -1.60 | ||||||
| Operating cashflow per share | $ | 0.50 | 0.39 | ||||||
| Capex per share | $ | 0.16 | 0.12 | ||||||
| FCF per share | $ | 0.35 | 0.27 | ||||||
| Free cash flow | $m | 37 | 29 | ||||||
| Net debt | $m | -16 | -23 | ||||||
| Book value equity | $m | 281 | 145 | ||||||
| Book value per share | $ | 2.64 | 1.37 | ||||||
| Number of shares | m | 106.65 | 105.81 | ||||||
| DPS (TTM paid) | $ | 0.03 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 1.09 | 2.12 | ||||||
| P/S LTM | x | 1.27 | 1.32 | ||||||
| P/FCF LTM | x | 8.26 | 10.72 | ||||||
| EV/EBITDA LTM | x | -1.94 | -1.66 | ||||||
| EV/Sales LTM | x | 1.30 | 0.46 | ||||||
| Earnings Yield LTM | % | -45.39% | -1.51% | ||||||
| FCF Yield | % | +12.11% | +9.33% | ||||||
| Quality | |||||||||
| ROE | % | -49.42% | -78.52% | ||||||
| ROIC | % | -3.32% | +40.78% | ||||||
| Operating margin | % | -8.52% | +67.38% | ||||||
| Gross margin | % | +75.88% | +71.67% | ||||||
| FCF/Sales | % | +15.34% | +12.27% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -4.24% | -7.73% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | -19.18% | -37.71% | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +1.03% | 0.00% | ||||||
| Dividend Growth | % | -32.95% | -100.00% | ||||||
| Payout Ratio | % | -2.27% | 0.00% | ||||||
| FCF/Debt | x | 0.21 | 0.17 | ||||||
| Net Debt/EBITDA | x | -0.06 | 0.02 | ||||||
| EBIT/Net interest | x | -1.82 | 14.10 | ||||||
| Net debt/market cap | % | +53.85% | +1.45% | ||||||
| Net debt/Equity | x | -0.06 | -0.16 | ||||||
| Gross debt/equity | x | 0.61 | 1.15 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free